Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

HUTCHMED and AstraZeneca begin Phase III trial of lung cancer treatment

November 24, 2021 Research and Development

HUTCHMED Limited and AstraZeneca have initiated SACHI, a China Phase III study of Savolitinib (ORPATHYS®), an oral, potent, and highly …
News

NICE recommends Opdivo (nivolumab) for oesophageal cancer treatment

November 17, 2021 Research and Development

NICE has recommended nivolumab for the adjuvant treatment of completely resected oesophageal or gastro-oesophageal junction (GOJ) cancer, in adults who …
News

Health experts warn of a ‘hidden pandemic’ of antibiotic-resistant infections

November 17, 2021 Research and Development

UK health officials have warned that a ‘hidden pandemic’ of antibiotic-resistant infections could occur if people take antibiotics to fight …
News

Pfizer deal allows generic versions of COVID pill for low-income countries

November 17, 2021 Research and Development

Pfizer has announced a deal for the production of its antiviral Paxlovid pill to generic drug manufactures, for supply in …
News

US secures over 750,000 doses of GSK-Vir COVID-19 drug

November 17, 2021 Research and Development

The US has secured GSK and Vir Biotechnology’s antibody-based COVID-19 treatment, through signing contracts worth approximately $1 billion, according to …
News

Pfizer ask FDA to authorise COVID booster in adults

November 10, 2021 Research and Development

Pfizer have requested that the FDA authorise booster shots of the COVID-19 vaccine in all Americans 18 and older, citing …
News

COMPASS Pathways announce positive results in clinical trial for treatment-resistant depression

November 10, 2021 Research and Development

COMPASS Pathways, a mental health care company dedicated to the acceleration of patient access to evidence-based innovation in mental health, …
News

Pleco Therapeutics partners with Hyloris to develop novel cancer agent

November 10, 2021 Research and Development

Specialty biopharma company, Pleco Therapeutics, have announced the beginning of a strategic collaboration with Hyloris Pharmaceuticals, to develop and commercialise …
News

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …
Appointment
kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …
Appointment

Study reveals Alzheimer’s spreads differently than previously thought

November 3, 2021 Research and Development

A University of Cambridge research team has used human data to quantify the speed of different processes that lead to …
News

Clinical trial shows promise for aggressive eye cancer treatment

November 3, 2021 Research and Development

A clinical trial with University of Liverpool researchers at The Clatterbridge Cancer Centre has shown great promise for an immunotherapy …
News

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …
Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
Feature

Breakthrough status given to Renew Bioscience’s Alzheimer’s treatment

November 3, 2021 Research and Development

Renew Bioscience announced it has received Breakthrough Device Designation status from the FDA for the Cerezen® Device, a novel treatment …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026